Patient with factor H deficiency associated hemolytic uremic syndrome looses fourth renal allograft What comes next?

Size: px
Start display at page:

Download "Patient with factor H deficiency associated hemolytic uremic syndrome looses fourth renal allograft What comes next?"

Transcription

1 Patient with factor H deficiency associated hemolytic uremic syndrome looses fourth renal allograft What comes next? Anja Lehnhardt 1, Andreas Richterich 2, Dirk E. Mueller-Wiefel 1, Markus J. Kemper 1 Department of 1 Pediatric Nephrology and 2 Psychosomatics in Children and Adolescents, University Medical Center Hamburg- Eppendorf, Germany

2 Introduction At 2½ years, patient M presented with D(+) hemolytic uremic syndrome (HUS) Shigatoxin negative microangiopathic hemolytic anemia thrombocytopenia renal impairement In most cases of D(+) HUS renal replacement treatment only needed short term

3 Plasmaexchange/ Hemodialysis Peritoneal dialysis Renal transplant 1st 2nd 11 yr old sister died from HUS when M. was 6,5 yrs old Heterozygous mutation in complement factor H gene familial HUS recurrent peritonitic episodes (bacterial and fungal) Age (years)

4 Factor H deficiency associated HUS Plasma protein made in the liver Involved in complement regulation Plasma exchange as treatment to replace mutated factor H only partially successful Renal transplant as treatment of ESRD but not HUS, high risk of disease recurrence

5 Plasmaexchange/ Hemodialysis Peritoneal dialysis Renal transplant High allo-antibody levels After third renal transplant: - Deafness - Change in behavior: aggressive 1st 2nd 3rd Age (years)

6 Psychiatric complications renal transplant 3rd aggressive ++ psychotic 4th Organic hallucinosis? Caused by: - Prolonged ICU stay (sedatives/narcotics) - Immunsuppressive treatment (steroids) - HUS... Magical Thinking (Mangas, computer) Impulsive/ aggressive

7 Family Background Working class family Eldest of three siblings (two sisters) Little died from same disease, Frustration and aggressions built up within family, hardly accessible by counseling Compliance difficult

8 Psychosocial Background Irregular schoolvisits, since the age of 13 school for deaf children Communicates mainly by sign language and written words Cognitive development delayed, is able to understand illness Suicidal tendencies ( I dont want to live anymore ) with excessive drinking despite fluidrestriction since after 2nd transplant

9 Plasmaexchange/ Hemodialysis Peritoneal dialysis 16 yrs of treatment During first 10 years of illness 700 days in hospital Renal transplant 1st 2nd 3rd 4th Age (years) Deafness HUS recurrence Psychiatric disease Repeat surgeries Chronic renal failure

10 At present Living with parents and sister, living in own house Transferred to adult service Hemodialysis 3 sessions/ week School for deaf children Olanzapine No counselling

11 Conclusion QUESTIONS Longterm hemodialysis as nocturnal home hemodialysis until other options available? Combined liver-kidney transplant? Is the additional psychiatric disease per se contraindication for another transplant?

12 Conclusion QUESTIONS - general How many transplants should be performed in patients with recurrent disease (HUS/FSGS)? When does the child have the right to say NO to have dialysis or another transplant? How can we optimize psychosocial care for children with recurrent diseases and their families? Are there special aspects of transfer to adult services in these patients?

M.Weitz has documented that he has no relevant financial relationships to disclose or conflict of interest to resolve.

M.Weitz has documented that he has no relevant financial relationships to disclose or conflict of interest to resolve. M.Weitz has documented that he has no relevant financial relationships to disclose or conflict of interest to resolve. Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic

More information

Dr. E.SUDHA (Fellow in Pediatric Nephrology) DEPT OF PEDIATRIC NEPHROLOGY & DIALYSIS Dr.MEHTA CHILDRENS HOSPITAL

Dr. E.SUDHA (Fellow in Pediatric Nephrology) DEPT OF PEDIATRIC NEPHROLOGY & DIALYSIS Dr.MEHTA CHILDRENS HOSPITAL Dr. E.SUDHA (Fellow in Pediatric Nephrology) DEPT OF PEDIATRIC NEPHROLOGY & DIALYSIS Dr.MEHTA CHILDRENS HOSPITAL CASE HISTORY 4 yrs old previously well boy Born to 2 nd degree consanguinity Fever x 5 days

More information

ESRD Mortality. Causes of CKD in Children. Causes of Late Graft Failure. 5-Year Allograft Survival. All-cause mortality rates, 2005, by age

ESRD Mortality. Causes of CKD in Children. Causes of Late Graft Failure. 5-Year Allograft Survival. All-cause mortality rates, 2005, by age North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Causes of CKD in Children Founded in 1992 78 participating centers in Canada & U.S. 16,339 CKD patients age 0 18 years 9,506 renal

More information

RECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT. J. H. Helderman,MD,FACP,FAST

RECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT. J. H. Helderman,MD,FACP,FAST RECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT J. H. Helderman,MD,FACP,FAST Vanderbilt University Medical Center Professor of Medicine, Pathology and Immunology Medical Director, Vanderbilt Transplant

More information

United States Renal Data System (USRDS) International Data Collection Form

United States Renal Data System (USRDS) International Data Collection Form United States Renal Data System (USRDS) International Data Collection Form This form is designed to solicit information on the population of End-Stage Renal Disease (ESRD) patients in your country who

More information

End-Stage Renal Disease. Anna Vinnikova, M.D. Associate Professor of Medicine Division of Nephrology

End-Stage Renal Disease. Anna Vinnikova, M.D. Associate Professor of Medicine Division of Nephrology End-Stage Renal Disease Anna Vinnikova, M.D. Associate Professor of Medicine Division of Nephrology ESRD : Life with renal replacement therapy CASE: 18 month old male with HUS develops ESRD PD complicated

More information

Beyond Plasma Exchange: Targeted Therapy for Thrombotic Thrombocytopenic Purpura

Beyond Plasma Exchange: Targeted Therapy for Thrombotic Thrombocytopenic Purpura Beyond Plasma Exchange: Targeted Therapy for Thrombotic Thrombocytopenic Purpura Kristen Knoph, PharmD, BCPS PGY2 Pharmacotherapy Resident Pharmacy Grand Rounds April 25, 2017 2016 MFMER slide-1 Objectives

More information

Atypical Hemolytic Uremic Syndrome: When the Environment and Mutations Affect Organ Systems. A Case Report with Review of Literature

Atypical Hemolytic Uremic Syndrome: When the Environment and Mutations Affect Organ Systems. A Case Report with Review of Literature Atypical Hemolytic Uremic Syndrome: When the Environment and Mutations Affect Organ Systems. A Case Report with Review of Literature Mouhanna Abu Ghanimeh 1, Omar Abughanimeh 1, Ayman Qasrawi 1, Abdulraheem

More information

DRUG NAME: Eculizumab Brand(s): Soliris DOSAGE FORM/ STRENGTH: 10 mg/ml (300 mg per vial)

DRUG NAME: Eculizumab Brand(s): Soliris DOSAGE FORM/ STRENGTH: 10 mg/ml (300 mg per vial) Preamble: A confirmed diagnosis of atypical hemolytic uremic syndrome (ahus) is required for eculizumab funding. The information below is to provide clinicians with context for how a diagnosis of ahus

More information

Risk factors of chronic renal failure after atypical Hemolytic Uremic Syndrome under plasmatherapy

Risk factors of chronic renal failure after atypical Hemolytic Uremic Syndrome under plasmatherapy Risk factors of chronic renal failure after atypical Hemolytic Uremic Syndrome under plasmatherapy Professeur Eric Rondeau Urgences néphrologiques et Transplantation rénale Hôpital Tenon, Paris WWA SFH

More information

COGNITIVE ALTERATIONS IN CHRONIC KIDNEY DISEASE K K L E E

COGNITIVE ALTERATIONS IN CHRONIC KIDNEY DISEASE K K L E E COGNITIVE ALTERATIONS IN CHRONIC KIDNEY DISEASE K K L E E Attention Problem Solving Language Cognitive Domains Decision Making Memory Reasoning The Cardiovascular Health Cognition Study shows higher S

More information

Cedars Sinai Medical Center Pediatric Electives

Cedars Sinai Medical Center Pediatric Electives PE 235.03 MEDICAL GENETICS COURSE CHAIR: John M. Graham, M.D., ScD.. By arrangement - Please contact the Student Coordinator 1. Counseling techniques and the approach to the patient and family with hereditary

More information

Foodborne Outbreak of E. coli Infections and Hemolytic Uremic Syndrome in Germany, 2011

Foodborne Outbreak of E. coli Infections and Hemolytic Uremic Syndrome in Germany, 2011 Foodborne Outbreak of E. coli Infections and Hemolytic Uremic Syndrome in Germany, 2011 Kirk Smith, DVM, MS, PhD Supervisor Foodborne, Vectorborne and Zoonotic Diseases Unit Minnesota Department of Health

More information

Pediatric GU Dysfunction

Pediatric GU Dysfunction Pediatric GU Dysfunction Assessment of pediatric renal function Signs and symptoms Laboratory tests Radiological tests Nursing considerations Psychosocial and developmental considerations GU Disorders

More information

Applying clinical guidelines treating and managing CKD

Applying clinical guidelines treating and managing CKD Applying clinical guidelines treating and managing CKD Develop patient treatment plan according to level of severity. Source: Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012

More information

In-Center Hemodialysis Six Times per Week versus Three Times per Week

In-Center Hemodialysis Six Times per Week versus Three Times per Week Journal Club du 25 novembre 2010 In-Center Hemodialysis Six Times per Week versus Three Times per Week The FHN Trial Group N Engl J Med 2010 Frequent Hemodialysis Network Introduction fréquence? dose?

More information

Saudi Population & Genetic Diseases

Saudi Population & Genetic Diseases CHALLENGES TO TREATMENT OF INHERITED METABOLIC DISORDES: THE SAUDI EXPEREINCE Zuhair N. Al-Hassnan, MD Dept. of Medical Genetics, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

More information

THE CONSERVATIVE CARE PATHWAY

THE CONSERVATIVE CARE PATHWAY THE CONSERVATIVE CARE PATHWAY Dr. Gaylene Hargrove Sept. 19, 2015 Island Health Renal Program End of Life Conference Learning Objectives Describe and discuss what defines conservative care. Identify key

More information

13. POINT-OF-CARE CREATININE TESTING IN HIGH- RISK PATIENTS

13. POINT-OF-CARE CREATININE TESTING IN HIGH- RISK PATIENTS How to Cite this article: Point-of-Care Creatinine Testing in High-Risk Patients - ejifcc 20/01 2009 http://www.ifcc.org 13. POINT-OF-CARE CREATININE TESTING IN HIGH- RISK PATIENTS Yolanda B. de Rijke

More information

Home Modalities: Patient Selection + Program Growth= Success! April 18, 2018

Home Modalities: Patient Selection + Program Growth= Success! April 18, 2018 Home Modalities: Patient Selection + Program Growth= Success! Deb DeWalt, MSN, RN Quality Improvement Director Sue Swan-Blohm, BS, OCDT Quality Improvement Coordinator April 18, 2018 Benefits of Home Modalities

More information

RECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT

RECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT RECURRENT AND DE NOVO RENAL DISEASES IN THE ALLOGRAFT HISTOPATHOLOGIC DISORDERS AFFECTING THE ALLOGRAFT OTHER THAN REJECTION RECURRENT DISEASE DE NOVO DISEASE TRANSPLANT GLOMERULOPATHY Glomerular Non-glomerular

More information

Utopia Health Career Center, LLC. Do not distribute without permission.

Utopia Health Career Center, LLC. Do not distribute without permission. Introduction What is dialysis and a brief history. What laws govern dialysis treatments. How to ensure high quality care for patients. How to behave in a professional way. How to become certified. We don

More information

The University of Arizona Pediatric Residency Program. Primary Goals for Rotation. Nephrology

The University of Arizona Pediatric Residency Program. Primary Goals for Rotation. Nephrology The University of Arizona Pediatric Residency Program Primary Goals for Rotation Nephrology 1. GOAL: Understand the general pediatrician's role in diagnosis and management of hypertension in children.

More information

Pathology of Complement Mediated Renal Disease

Pathology of Complement Mediated Renal Disease Pathology of Complement Mediated Renal Disease Mariam Priya Alexander, MD Associate Professor of Pathology GN Symposium Hong Kong Society of Nephrology July 8 th, 2017 2017 MFMER slide-1 The complement

More information

Spectrum of complement-mediated thrombotic microangiopathies after kidney transplantation

Spectrum of complement-mediated thrombotic microangiopathies after kidney transplantation Spectrum of complement-mediated thrombotic microangiopathies after kidney transplantation Marius Miglinas Vilnius university hospital: Nephrology center, Center of Rare Kidney Diseases Vilnius university

More information

The New Kidney Allocation System: What You Need to Know. Quality Insights Renal Network 3 Annual Meeting October 2, 2014

The New Kidney Allocation System: What You Need to Know. Quality Insights Renal Network 3 Annual Meeting October 2, 2014 The New Kidney Allocation System: What You Need to Know Quality Insights Renal Network 3 Annual Meeting October 2, 2014 Pre Dialysis Era Dialysis Status in USA 500,000 patients on dialysis in 2013 100,000

More information

Hemolytic Uremic Syndrome

Hemolytic Uremic Syndrome Hemolytic Uremic Syndrome Francesco Emma Division of Nephrology and Dialysis Bambino Gesù Children s Hospital, IRCCS Rome, Italy Hemolytic Uremic Syndrome (HUS) microangiopathic hemolytic anemia thrombocytopenia

More information

Recent advances in pathogenesis & treatment of ahus

Recent advances in pathogenesis & treatment of ahus Recent advances in pathogenesis & treatment of ahus Miquel Blasco Pelicano Nephrology and Kidney Transplant Unit Hospital Clínic, Barcelona Atypical Hemolytic Uremic Syndrome (ahus) Ultra-rare disease:

More information

Atypical IgA Nephropathy

Atypical IgA Nephropathy Atypical IgA Nephropathy Richard J. Glassock, MD, MACP Geffen School of Medicine at UCLA XXXIII Chilean Congress of Nephrology, Hypertension and Transplantation Puerto Varas, Chile October 6, 2016 IgA

More information

Primary causes: Complement dysregulation (50% of non-shiga toxin-producing E. coli ) Secondary causes:

Primary causes: Complement dysregulation (50% of non-shiga toxin-producing E. coli ) Secondary causes: General department INTRODUCTION The hemolytic uremic syndrome (HUS): microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury One of the main causes of acute kidney injury in children

More information

Guidelines for the psychological management of chronic kidney disease patients (for the Psychologist)

Guidelines for the psychological management of chronic kidney disease patients (for the Psychologist) Indian J Nephrol 2005;15, Supplement 1: S103-S108 S 103 Guidelines for the psychological management of chronic kidney disease patients (for the Psychologist) Introduction With increasing levels of sophistication

More information

THE KIDNEY AND SLE LUPUS NEPHRITIS

THE KIDNEY AND SLE LUPUS NEPHRITIS THE KIDNEY AND SLE LUPUS NEPHRITIS JACK WATERMAN DO FACOI 2013 NEPHROLOGY SIR RICHARD BRIGHT TERMINOLOGY RENAL INSUFFICIENCY CKD (CHRONIC KIDNEY DISEASE) ESRD (ENDSTAGE RENAL DISEASE) GLOMERULONEPHRITIS

More information

New insights in thrombotic microangiopathies : TTP and ahus

New insights in thrombotic microangiopathies : TTP and ahus New insights in thrombotic microangiopathies : TTP and ahus Dr Catherine LAMBERT Hematology Cliniques universitaires Saint-Luc Catherine.lambert@uclouvain.be New insights in thrombotic microangiopathies

More information

Starting with Home Dialysis. Budapest Nephrology School 2016 Ágnes Haris MD, PhD, Kálmán Polner MD St. Margit Hospital, Budapest

Starting with Home Dialysis. Budapest Nephrology School 2016 Ágnes Haris MD, PhD, Kálmán Polner MD St. Margit Hospital, Budapest Starting with Home Dialysis Budapest Nephrology School 2016 Ágnes Haris MD, PhD, Kálmán Polner MD St. Margit Hospital, Budapest Major concept of the RRT modality selection Hemodialysis Peritoneal dialysis

More information

TMA CASE STUDY. Pamela Harmon, RN & Keturah Tomlin, RN Toronto General Hospital Apheresis Unit

TMA CASE STUDY. Pamela Harmon, RN & Keturah Tomlin, RN Toronto General Hospital Apheresis Unit TMA CASE STUDY Pamela Harmon, RN & Keturah Tomlin, RN Toronto General Hospital Apheresis Unit Cumulative fraction of patients free of events ahus is a catastrophic disease that can result in sudden & progressive

More information

Shared Decision Making established kidney failure dialysis. Deciding what type of dialysis to choose for established kidney failure

Shared Decision Making established kidney failure dialysis. Deciding what type of dialysis to choose for established kidney failure Shared Decision Making established kidney failure Next clinical review date March 2018 Deciding what type of to choose for established kidney failure This short decision aid is to help you decide what

More information

Living Kidney Donation. Dr. Joseph Keith Melancon

Living Kidney Donation. Dr. Joseph Keith Melancon Living Kidney Donation Dr. Joseph Keith Melancon Thanks to our speaker! Keith Melancon, MD Chief Transplant Institute And Division Of Transplant Surgery; Medical Director GW/ Ron And Joy Paul Kidney Center

More information

Soliris (eculizumab) DRUG.00050

Soliris (eculizumab) DRUG.00050 Market DC Soliris (eculizumab) DRUG.00050 Override(s) Prior Authorization Approval Duration 1 year Medications Soliris (eculizumab) APPROVAL CRITERIA Paroxysmal Nocturnal Hemoglobinuria I. Initiation of

More information

You can sleep while I dialyze

You can sleep while I dialyze You can sleep while I dialyze Nocturnal Peritoneal Dialysis Dr. Suneet Singh Medical Director, PD, VGH Division of Nephrology University of British Columbia Acknowledgements Melissa Etheridge You can sleep

More information

Assisted Peritoneal Dialysis

Assisted Peritoneal Dialysis Assisted Peritoneal Dialysis BC Kidney Days Vancouver, BC Matthew Oliver MD MHS Sunnybrook Health Sciences Centre University of Toronto Oct 18, 2012 Declaration 2 Co-inventor of the Dialysis Measurement

More information

1) unexplained microangiopathic hemolytic anemia (Coombs negative anemia),

1) unexplained microangiopathic hemolytic anemia (Coombs negative anemia), Ravi Sarode, MD Consensus Process The TTP-CC subcommittee developed 7 key questions Sent to the 7 speakers for electronic voting in Yes or No format Will be published in JCA soon Q.1 Untreated TTP carries

More information

Kidney Disease and Failure. March 2018

Kidney Disease and Failure. March 2018 Kidney Disease and Failure March 2018 Objectives l State the function of the kidney l Define kidney disease l Identify tests and abnormal test results for kidney function l Recognize prevention and treatment

More information

What is meant by Thrombotic Microangiopathy (TMA)?

What is meant by Thrombotic Microangiopathy (TMA)? What is meant by Thrombotic Microangiopathy (TMA)? Thrombotic Microangiopathy (TMA) is a group of disorders characterized by injured endothelial cells, microangiopathic hemolytic anemia (MAHA), with its

More information

THROMBOTIC MICROANGIOPATHY. Jun-Ki Park 7/19/11

THROMBOTIC MICROANGIOPATHY. Jun-Ki Park 7/19/11 THROMBOTIC MICROANGIOPATHY Jun-Ki Park 7/19/11 TMAs are microvascular occlusive disorders characterized by systemic or intrarenal aggregation of platelets, thrombocytopenia, and mechanical injury to erythrocytes.

More information

SAMPLE. Chronic Kidney Disease, Evidence-Based Practice, and the Nutrition Care Process. Chapter 1

SAMPLE. Chronic Kidney Disease, Evidence-Based Practice, and the Nutrition Care Process. Chapter 1 Chapter 1 Chronic Kidney Disease, Evidence-Based Practice, and the Nutrition Care Process This guide follows the steps of the Nutrition Care Process (NCP) nutrition assessment, nutrition diagnosis, nutrition

More information

Enrico Verrina has documented that he has no relevant financial relationships to disclose or conflict of interest to resolve.

Enrico Verrina has documented that he has no relevant financial relationships to disclose or conflict of interest to resolve. Enrico Verrina has documented that he has no relevant financial relationships to disclose or conflict of interest to resolve. Should we always dialyze and transplant mentally disabled patients? Medical

More information

21th Budapest Nephrology School Ágnes Haris, Kálmán Polner

21th Budapest Nephrology School Ágnes Haris, Kálmán Polner 21th Budapest Nephrology School Ágnes Haris, Kálmán Polner 53 years old female, -worked as computer scientist, -lived with her husband and 2 children, -in excellent financial situation. Diagnosed with

More information

Acute Kidney Injury. Arvind Bagga All India Institute of Medical Sciences New Delhi, India

Acute Kidney Injury. Arvind Bagga All India Institute of Medical Sciences New Delhi, India Acute Kidney Injury Arvind Bagga All India Institute of Medical Sciences New Delhi, India What is AKI? Sudden loss of renal function, over hrdays, with derangement(s) in fluid balance, acid base & electrolytes

More information

April 18, Dear Mr. Blum and Dr. Conway:

April 18, Dear Mr. Blum and Dr. Conway: April 18, 2014 Dear Mr. Blum and Dr. Conway: On behalf of the undersigned patient and health professional organizations, thank you for meeting with us Wednesday, September 18, 2013. Our organizations were

More information

Internal Medicine Dialysis Provider Perspective Joe Ghata

Internal Medicine Dialysis Provider Perspective Joe Ghata Internal Medicine Dialysis Provider Perspective Joe Ghata Disclaimers 1 Learning Objectives Transition vs Transfer Healthcare Utilization Among AYA with ESRD Home hemodialysis Modalities Undocumented AYA

More information

Chronic Kidney Disease (CKD) Stages. CHRONIC KIDNEY DISEASE Treatment Options. Incident counts & adjusted rates, by primary diagnosis Figure 2.

Chronic Kidney Disease (CKD) Stages. CHRONIC KIDNEY DISEASE Treatment Options. Incident counts & adjusted rates, by primary diagnosis Figure 2. Chronic Kidney Disease (CKD) Stages Stage 1 GFR > 90 (evidence of renal disease) Stage 2 GFR 60-89 Stage 3 GFR 30-59 Stage 4 GFR 15-29 Stage 5 GFR

More information

A Study of substance abuse among chronic kidney disease patients having psychiatric illness undergoing haemodialysis

A Study of substance abuse among chronic kidney disease patients having psychiatric illness undergoing haemodialysis International Journal of Multidisciplinary and Current Research Research Article ISSN: 2321-3124 Available at: http://ijmcr.com A Study of substance among chronic kidney disease patients having psychiatric

More information

A 60 year old woman with altered mental status and thrombotic microangiopathy. Josh Veatch

A 60 year old woman with altered mental status and thrombotic microangiopathy. Josh Veatch A 60 year old woman with altered mental status and thrombotic microangiopathy Josh Veatch Previously healthy 60 year old woman 2 3 months of fatigue following a URI, transient episodes being out of it

More information

Specific Basic Standards for Osteopathic Fellowship Training in Nephrology

Specific Basic Standards for Osteopathic Fellowship Training in Nephrology Specific Basic Standards for Osteopathic Fellowship Training in Nephrology American Osteopathic Association and American College of Osteopathic Internists BOT Rev. 2/2011 These specific basic standards

More information

5. Indications for the use of urokinase in peritoneal dialysis associated peritonitis

5. Indications for the use of urokinase in peritoneal dialysis associated peritonitis 5. Indications for the use of urokinase in peritoneal dialysis associated peritonitis Date written: February 2003 Final submission: July 2004 Guidelines (Include recommendations based on level I or II

More information

ahus A PATIENT S GUIDE To learn more about ahus, visit Copyright 2011, Alexion Pharmaceuticals, Inc. All rights reserved.

ahus A PATIENT S GUIDE To learn more about ahus, visit  Copyright 2011, Alexion Pharmaceuticals, Inc. All rights reserved. To learn more about ahus, visit www.ahussource.com ahus A PATIENT S GUIDE Copyright 2011, Alexion Pharmaceuticals, Inc. All rights reserved. SOL 1169 BECOME EMPOWERED By learning more and taking control

More information

Educational Goals & Objectives

Educational Goals & Objectives Educational Goals & Objectives The nephrology rotation will provide the resident with an opportunity to evaluate and manage patients across the spectrum of renal disorders in both the inpatient and outpatient

More information

Building a clinical service for children with CKD in a developing country

Building a clinical service for children with CKD in a developing country Building a clinical service for children with CKD in a developing country ALANEPE X LATIN AMERICA CONGRESS OF PEDIATRIC NEPHROLOGY Dr. Maolynne Miller JAMAICA WEST INDIES Paediatrician Paediatric Nephrologist

More information

Exer Ex cise Pa P tien tien with End End stag sta e g renal Disease

Exer Ex cise Pa P tien tien with End End stag sta e g renal Disease Exercise in Patients with End stage Exercise in Patients with End stage renal Disease Chronic renal failure : gradual and progressive loss of the ability of the kidneys to function Structural kidney damage

More information

Study of Prevalence of Depression and Suicidal Tendencies in the Patients of End Stage Renal Disease Treated with Hemodialysis

Study of Prevalence of Depression and Suicidal Tendencies in the Patients of End Stage Renal Disease Treated with Hemodialysis Original article Study of Prevalence of Depression and Suicidal Tendencies in the Patients of End Stage Renal Disease Treated with Hemodialysis 1 Partha Pratim De, 2 Madhumita De, 3 Sabyasachi Roy, 4 Kakali

More information

Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College

Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College Dr. Rai Muhammad Asghar Associate Professor Head of Pediatric Department Rawalpindi Medical College AN APPROACH TO BLEEDING DISORDERS NORMAL HEMOSTASIS After injury, 3 processes halt bleeding Vasoconstriction

More information

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality Shannon H. Norris, BSN, RN June 6, 2018 Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality DISCUSSION: End Stage

More information

Overview. Evaluation of Potential Kidney Transplant Recipients. Projected Years of Life in Patients with ESRD

Overview. Evaluation of Potential Kidney Transplant Recipients. Projected Years of Life in Patients with ESRD Evaluation of Potential Kidney Transplant Recipients Donald E. Hricik MD Professor of Medicine and Chief, Division of Nephrology and Hypertension University Hospitals Case Medical Center Conflict of Interest

More information

Clinical Study Eculizumab Therapy Leads to Rapid Resolution of Thrombocytopenia in Atypical Hemolytic Uremic Syndrome

Clinical Study Eculizumab Therapy Leads to Rapid Resolution of Thrombocytopenia in Atypical Hemolytic Uremic Syndrome Hindawi Publishing Corporation Advances in Hematology Volume 214, Article ID 295323, 7 pages http://dx.doi.org/1.1155/214/295323 Clinical Study Therapy Leads to Rapid Resolution of Thrombocytopenia in

More information

Non-Adherence: How to Improve the Therapeutic Relationship with Difficult Patients

Non-Adherence: How to Improve the Therapeutic Relationship with Difficult Patients Non-Adherence: How to Improve the Therapeutic Relationship with Difficult Patients Bradford Strijack MD MHSc FRCPC Clinical Assistant Professor University of British Columbia October 7, 2016 None Disclosures

More information

Jadranka Buturović-Ponikvar Department of Nephrology, University Medical Center, Ljubljana, Slovenia

Jadranka Buturović-Ponikvar Department of Nephrology, University Medical Center, Ljubljana, Slovenia Jadranka Buturović-Ponikvar Department of Nephrology, University Medical Center, Ljubljana, Slovenia Hemodialysis or kidney transplantation what is better? Jadranka Buturović-Ponikvar Department of Nephrology,

More information

Cancer rehabilitation in Germany

Cancer rehabilitation in Germany Cancer rehabilitation in Germany Corinna Bergelt, PhD Hamburg-Eppendorf University Medical Centre Hamburg, Germany Background Social security system is organized as a statutory insurance system Long tradition:

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Lapeyraque A-L, Malina M, Fremeaux-Bacchi V, et al. Eculizumab

More information

Fluid Management Workbook

Fluid Management Workbook Patient s Name Fluid Management Workbook Developed by the ESRD Network 14 Patient Engagement Learning and Action Network (PE LAN), in partnership with: ESRD patients and families Baylor Scott & White DaVita

More information

PSYCHOSOCIAL ASPECTS OF RENAL DISEASE

PSYCHOSOCIAL ASPECTS OF RENAL DISEASE PSYCHOSOCIAL ASPECTS OF RENAL DISEASE Anastasia Anastasiou Palliative care symposium Aug 13 They ll be fine What we will cover Grief and loss Emotional Reactions Sex/sexuality Non-Compliance CALD Quality

More information

Thrombotic thrombocytopenic purpura: a look at the future

Thrombotic thrombocytopenic purpura: a look at the future Thrombotic thrombocytopenic purpura: a look at the future Andrea Artoni, MD Ph.D. Angelo Bianchi Bonomi Hemophilia and Thrombosis Center IRCCS Ca Granda Ospedale Maggiore Policlinico Milan, Italy andrea.artoni@policlinico.mi.it

More information

Measure Information Form

Measure Information Form Measure Information Form Project Title: Mineral and Bone Disorder Project Overview: Date: The Centers for Medicare & Medicaid Services (CMS) has contracted with the University of Michigan Kidney Epidemiology

More information

Liver Transplantation

Liver Transplantation 1 Liver Transplantation Department of Surgery Yonsei University Wonju College of Medicine Kim Myoung Soo M.D. ysms91@wonju.yonsei.ac.kr http://gs.yonsei.ac.kr History Development of Liver transplantation

More information

03/20/2019. Thank you for the invitation to speak. I have no conflicts of interest

03/20/2019. Thank you for the invitation to speak. I have no conflicts of interest Raj Munshi, MD Annual Dialysis Conference 2019 Thank you for the invitation to speak I have no conflicts of interest Expected remaining lifetime in years of prevalent patients by initial ESRD modality,

More information

RISING HEALTHCARE COSTS: A Deeper Look Into. Catastrophic Claims by Stacy Borans, MD, Chief Medical Officer, Advanced Medical Strategies

RISING HEALTHCARE COSTS: A Deeper Look Into. Catastrophic Claims by Stacy Borans, MD, Chief Medical Officer, Advanced Medical Strategies RISING HEALTHCARE COSTS: A Deeper Look Into Catastrophic Claims by Stacy Borans, MD, Chief Medical Officer, Advanced Medical Strategies 4 July 2013 The Self-Insurer Self-Insurers Publishing Corp. All rights

More information

2 Treatment Approaches

2 Treatment Approaches 2 Treatment Approaches Hemodialysis is one of the three major treat- This section briefly describes each approach and ment approaches for end-stage renal disease discusses the associated equipment. Table

More information

Brief communication (Original)

Brief communication (Original) Asian Biomedicine Vol. 8 No. 1 February 2014; 67-73 DOI: 10.5372/1905-7415.0801.263 Brief communication (Original) Long-term clinical effects of treatment by daytime ambulatory peritoneal dialysis with

More information

Department of Nephrology

Department of Nephrology OUTCOMES DIVISION OF MEDICINE Department of Nephrology About Cleveland Clinic Florida Cleveland Clinic Florida s medical staff are dedicated physicians who have joined the clinic as salaried doctors to

More information

Living Donation in the Family Ethical and Medical Problems Dr Umberto Maggiore

Living Donation in the Family Ethical and Medical Problems Dr Umberto Maggiore Living Donation in the Family Ethical and Medical Problems Dr Umberto Maggiore SS Trapianti Rene-Pancreas UO Nefrologia (Dir Prof C Buzio) Az. Ospedaliero-Universitaria di Parma Parma, ITALY CATEGORIES

More information

Renal Network 9 / 10 March 10, 2009

Renal Network 9 / 10 March 10, 2009 Strategies for Adherence Renal Network 9 / 10 March 10, 2009 Paul W. Crawford, M.D. F.A.C.P. Associates in Nephrology Medical Director, Evergreen Park FMC, Ross-Englewood FMC, Roseland FMC Dialysis Centers

More information

Adjusting to life after kidney transplant. Dr. Rupi Sodhi Saint Louis University School of Medicine Division of Nephrology

Adjusting to life after kidney transplant. Dr. Rupi Sodhi Saint Louis University School of Medicine Division of Nephrology Adjusting to life after kidney transplant Dr. Rupi Sodhi Saint Louis University School of Medicine Division of Nephrology Thanks to our speaker! Dr. Rupi Sodhi Assistant Professor of Internal Medicine

More information

Hemolytic uremic syndrome: Investigations and management

Hemolytic uremic syndrome: Investigations and management Hemolytic uremic syndrome: Investigations and management SAWAI Toshihiro M.D., Ph.D. Department of Pediatrics, Shiga University of Medical Science Otsu, JAPAN AGENDA TMA; Thrombotic micro angiopathy STEC-HUS;

More information

Does Hemodialysis or Peritoneal Dialysis Provide a Better Quality of Life for Those with Chronic Kidney Disease? University of New Hampshire

Does Hemodialysis or Peritoneal Dialysis Provide a Better Quality of Life for Those with Chronic Kidney Disease? University of New Hampshire Running head: QUALITY OF LIFE AMONG CKD PATIENTS Does Hemodialysis or Peritoneal Dialysis Provide a Better Quality of Life for Those with Chronic Kidney Disease? University of New Hampshire QUALITY OF

More information

Drug dosing in patients with acute kidney injury

Drug dosing in patients with acute kidney injury Drug dosing in patients with acute kidney injury They don t know what they are doing Jan Jan T. T. Kielstein Department of of Nephrology and and Hypertension Medical School School Hannover Drug dosing

More information

Familial DDD associated with a gain-of-function mutation in complement C3.

Familial DDD associated with a gain-of-function mutation in complement C3. Familial DDD associated with a gain-of-function mutation in complement C3. Santiago Rodríguez de Córdoba, Centro de investigaciones Biológicas, Madrid Valdés Cañedo F. and Vázquez- Martul E., Complejo

More information

PSYCHOSOCIAL ASPECTS OF DIALYSIS AND RENAL TRANSPLANT

PSYCHOSOCIAL ASPECTS OF DIALYSIS AND RENAL TRANSPLANT PSYCHOSOCIAL ASPECTS OF DIALYSIS AND RENAL TRANSPLANT Pages with reference to book, From 99 To 100 Imtiazul Haq, Anwar Naqvi, Adeebul Hasan Rizvi ( Psychosocial Centre, Jinnah Postgraduate Medical Centre

More information

HUS-MPGN-TTP. & related disorders

HUS-MPGN-TTP. & related disorders ES-PCR 4 th International Conference HUS-MPGN-TTP & related disorders Current diagnosis and therapy of hemolytic uremic syndrome (HUS), membranoproliferative glomerulonephritis (MPGN), thrombotic thrombocytopenic

More information

Ontario s Referral and Listing Criteria for Adult Kidney Transplantation

Ontario s Referral and Listing Criteria for Adult Kidney Transplantation Ontario s Referral and Listing Criteria for Adult Kidney Transplantation Version 3.0 Trillium Gift of Life Network Adult Kidney Transplantation Referral & Listing Criteria PATIENT REFERRAL CRITERIA: The

More information

Soliris. Soliris (eculizumab) Description

Soliris. Soliris (eculizumab) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.85.11 Subject: Soliris Page: 1 of 5 Last Review Date: September 20, 2018 Soliris Description Soliris

More information

Adding Insult to Injury. Marlies Ostermann Consultant in Nephrology & Critical Care Guy s & St Thomas Hospital, London

Adding Insult to Injury. Marlies Ostermann Consultant in Nephrology & Critical Care Guy s & St Thomas Hospital, London Acute Kidney Injury Adding Insult to Injury Marlies Ostermann Consultant in Nephrology & Critical Care Guy s & St Thomas Hospital, London Content 1. Brief review of AKI and its impact 2. Comments on the

More information

Phosphate Management Guideline for Patients Receiving Extended Duration Hemodialysis

Phosphate Management Guideline for Patients Receiving Extended Duration Hemodialysis IAMHD HOME HEMODIALYSIS CLINICAL PRACTICE STANDARDS AND PROCEDURES Phosphate Management Guideline for Patients Receiving Extended Duration Hemodialysis PRINTED copies of Clinical Practice Standards and

More information

Sheena Surindran Grand Rounds 2/15/11

Sheena Surindran Grand Rounds 2/15/11 Sheena Surindran Grand Rounds 2/15/11 Affects 5 12 person per million / year 5 10% associated with myeloma Median survival without treatment is 12 40 months Most commonly affected organs are kidney, heart

More information

St George Hospital Renal Department Guideline: INTERNAL ONLY ANTICOAGULATION - COMMENCEMENT OF HAEMODIALYSIS

St George Hospital Renal Department Guideline: INTERNAL ONLY ANTICOAGULATION - COMMENCEMENT OF HAEMODIALYSIS ANTICOAGULATION - COMMENCEMENT OF HAEMODIALYSIS Summary Aim: To prevent clotting of the extracorporeal circuit during haemodialysis If there are no contraindications, heparin can be used. In the first

More information

Options in Renal Replacement Therapy: When, whom, which? Prof Dr. Serhan Tuğlular Marmara University Medical School Division of Nephrology

Options in Renal Replacement Therapy: When, whom, which? Prof Dr. Serhan Tuğlular Marmara University Medical School Division of Nephrology Options in Renal Replacement Therapy: When, whom, which? Prof Dr. Serhan Tuğlular Marmara University Medical School Division of Nephrology CKD Classification Stage Description GFR (ml/min/1.73.m2) 1 Kidney

More information

3/5/18. Background. Registry Reports. Dialysis Registry Update and Future Directions

3/5/18. Background. Registry Reports. Dialysis Registry Update and Future Directions Dialysis Registry Update and Future Directions Annabelle N. Chua, MD March 4, 2018 Background Founded in 1987 as a transplant registry Expanded registry to include dialysis (1992) and CKD (1994) Patient

More information

Pathogenic mechanisms in VTEC-associated HUS

Pathogenic mechanisms in VTEC-associated HUS Pathogenic mechanisms in VTEC-associated HUS Maurizio Brigotti Department of Experimental Pathology University of Bologna, Italy The main cause of acute renal failure in children under 2-3 years is the

More information

Is a kidney transplant right for me?

Is a kidney transplant right for me? Is a kidney transplant right for me? Your guide to the transplant process www.esrdncc.org Contents Introduction 3 What is a Transplant Center? 4 What is the Waiting List? 5 What Happens After the Surgery?

More information

Patient Description and Diagnosis: Sarah Jones is a 50-year-old female, 5 4, 131

Patient Description and Diagnosis: Sarah Jones is a 50-year-old female, 5 4, 131 Julia Kaesberg Counseling Session KNH 413 February 27 th, 2014 Patient Description and Diagnosis: Sarah Jones is a 50-year-old female, 5 4, 131 pounds and her usual body weight is 125 pounds. Her %UBW

More information

Part VI: Summary of the risk management plan by product

Part VI: Summary of the risk management plan by product Part VI: Summary of the risk management plan by product VI.1 Elements for summary tables in the EPAR VI.1.1 Summary table of Safety concerns Summary of safety concerns Important identified risks Hepatotoxic

More information

Clinical pathological correlations in AKI

Clinical pathological correlations in AKI Clinical pathological correlations in AKI Dr. Rajasekara chakravarthi Director - Nephrology Star Kidney Center, Star Hospitals Renown clinical services India Introduction AKI is common entity Community

More information